Improving Bayesian estimation of Vaccine Efficacy

03/07/2021

∙

A full Bayesian approach to the estimation of Vaccine Efficacy is presented, which is an improvement over the currently used exact method conditional on the total number of cases. As an example, we reconsider the statistical sections of the BioNTech/Pfizer protocol, which in 2020 has led to the first approved anti-Covid-19 vaccine.

READ FULL TEXT

Improving Bayesian estimation of Vaccine Efficacy

Bayesian adjustment for preferential testing in estimating the COVID-19 infection fatality rate: Theory and methods

Modelling death rates due to COVID-19: A Bayesian approach

Estimating undocumented Covid-19 infections in Cuba by means of a hybrid mechanistic-statistical approach

Assessing Vaccine Durability in Randomized Trials Following Placebo Crossover

A Python Package to Detect Anti-Vaccine Users on Twitter

Estimating SARS-CoV-2-positive Americans using deaths-only data

What is the probability that a vaccinated person is shielded from Covid-19? A Bayesian MCMC based reanalysis of published data with emphasis on what should be reported as `effi

Improving Bayesian estimation of Vaccine Efficacy

Related Research

Bayesian adjustment for preferential testing in estimating the COVID-19 infection fatality rate: Theory and methods

Modelling death rates due to COVID-19: A Bayesian approach

Estimating undocumented Covid-19 infections in Cuba by means of a hybrid mechanistic-statistical approach

Assessing Vaccine Durability in Randomized Trials Following Placebo Crossover

A Python Package to Detect Anti-Vaccine Users on Twitter

Estimating SARS-CoV-2-positive Americans using deaths-only data

What is the probability that a vaccinated person is shielded from Covid-19? A Bayesian MCMC based reanalysis of published data with emphasis on what should be reported as `effi